Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Challenges and opportunities for nephrology in Western Europe

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Arterial oxygen content regulates plasma erythropoietin independent of arterial oxygen tension: a blinded crossover study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. U-shaped dietary sodium-associated incidence of chronic kidney disease cautions against salt overrestriction in hypertension

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Renal 123I-MIBG Uptake before and after Live-Donor Kidney Transplantation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Vascular function in adults with cyanotic congenital heart disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Kontinuerlig glukosemonitorering af patienter med type 1- og type 2-diabetes i dialysebehandling

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Felodipine and renal function in lung transplantation: A randomized placebo-controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Benjamin C Storey
  • Natalie Staplin
  • Richard Haynes
  • Christina Reith
  • Jonathan Emberson
  • William G Herrington
  • David C Wheeler
  • Robert Walker
  • Bengt Fellström
  • Christoph Wanner
  • Martin J Landray
  • Colin Baigent
  • SHARP Collaborative Group (Bo Feldt-Rasmussen, members)
  • Bo Friis Feldt-Rasmussen (Medlem af forfattergruppering)
Vis graf over relationer

Markers of inflammation, including plasma C-reactive protein (CRP), are associated with an increased risk of cardiovascular disease, and it has been suggested that this association is causal. However, the relationship between inflammation and cardiovascular disease has not been extensively studied in patients with chronic kidney disease. To evaluate this, we used data from the Study of Heart and Renal Protection (SHARP) to assess associations between circulating CRP and LDL cholesterol levels and the risk of vascular and non-vascular outcomes. Major vascular events were defined as nonfatal myocardial infarction, cardiac death, stroke or arterial revascularization, with an expanded outcome of vascular events of any type. Higher baseline CRP was associated with an increased risk of major vascular events (hazard ratio per 3x increase 1.28; 95% confidence interval 1.19-1.38). Higher baseline LDL cholesterol was also associated with an increased risk of major vascular events (hazard ratio per 0.6 mmol/L higher LDL cholesterol; 1.14, 1.06-1.22). Higher baseline CRP was associated with an increased risk of a range of non-vascular events (1.16, 1.12-1.21), but there was a weak inverse association between baseline LDL cholesterol and non-vascular events (0.96, 0.92-0.99). The efficacy of lowering LDL cholesterol with simvastatin/ezetimibe on major vascular events, in the randomized comparison, was similar irrespective of CRP concentration at baseline. Thus, decisions to offer statin-based therapy to patients with chronic kidney disease should continue to be guided by their absolute risk of atherosclerotic events. Estimation of such risk may include plasma biomarkers of inflammation, but there is no evidence that the relative beneficial effects of reducing LDL cholesterol depends on plasma CRP concentration.

OriginalsprogEngelsk
TidsskriftKidney International
Vol/bind93
Udgave nummer4
Sider (fra-til)1000-1007
ISSN0085-2538
DOI
StatusUdgivet - 2018

ID: 52424295